ClassID:

21647

A61K2300/00 - page 9 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#2401
20180169201
2018-06-21

Combination of vaccination and inhibition of the PD-1 pathway

#2402
20180169197
2018-06-21

Agent for use in the case of fructose intolerance

#2403
20180169175
2018-06-21

Formulations for the treatment of disorders of the mouth, throat and respiratory tract

#2404
20180169168
2018-06-21

Anticancer composition containing mixed herbal medicine extract as active ingredient

#2405
20180169158
2018-06-21

Treatment for gastroesophageal reflux disease caused by a neurological disorder

#2406
20180169145
2018-06-21

COMPOSITIONS AND METHODS FOR USING LAMELLAR BODIES FOR THERAPEUTIC PURPOSES

#2407
20180169136
2018-06-21

USE OF PHARMACEUTICAL COMPOSITION IN PREPARATION OF DRUG FOR PROMOTING CHONDROCYTE GENERATION

#2408
20180169129
2018-06-21

Polynucleotide agents targeting angiotensinogen (AGT) and methods of use thereof

#2409
20180169123
2018-06-21

COMBINATION THERAPY WITH A FLAVAGLINE AND 2-DEOXYGLUCOSE

#2410
20180169122
2018-06-21

Synthetic composition and method for treating irritable bowel syndrome

#2411
20180169121
2018-06-21

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

#2412
20180169120
2018-06-21

COMBINATION THERAPY INCLUDING SAPC-DOPS FOR THE TREATMENT OF PANCREATIC CANCER

#2413
20180169115
2018-06-21

Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection

#2414
20180169108
2018-06-21

Drug Combinations For the Treatment of HIV

#2415
20180169101
2018-06-21

METHODS FOR TREATING CANCER

#2416
20180169100
2018-06-21

Cancer Stem Cell Targeting Compounds

#2417
20180169092
2018-06-21

PHARMACEUTICAL FORMULATIONS FOR TREATING GLAUCOMA AND METHODS FOR FABRICATING AND USING THEREOF

#2418
20180169091
2018-06-21

Levocetirizine and montelukast in the treatment of inflammation mediated conditions

#2419
20180169090
2018-06-21

ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM

#2420
20180169084
2018-06-21

Methods of Administering Pirfenidone Therapy

#2421
20180169081
2018-06-21

Treatment of debilitating fatigue

#2422
20180169069
2018-06-21

COMPOSITIONS AND METHODS FOR AMELIORATING CACHEXIA

#2423
20180169067
2018-06-21

COMBINATION DRUG THERAPIES FOR CANCER AND METHODS OF MAKING AND USING THEM

#2424
20180169056
2018-06-21

Oral use of zinc and copper gluconates in the treatment of digital dermatitis

#2425
20180169054
2018-06-21

Cat appeasing pheromone

#2426
20180169053
2018-06-21

Semiochemical compositions to reduce social conflicts with cats

#2427
20180169052
2018-06-21

AGENT FOR IMPROVING BRAIN FUNCTION AND AGENT FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT

#2428
20180169051
2018-06-21

Enteric soft capsules comprising polyunsaturated fatty acids

#2429
20180169042
2018-06-21

Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy

#2430
20180169038
2018-06-21

USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME

#2431
20180169029
2018-06-21

Dual assembly nanoparticles

#2432
20180169027
2018-06-21

Treating infection by a platelet-targeting microbe using nanoparticles

#2433
20180169017
2018-06-21

METHODS AND COMPOSITIONS FOR TREATING PROLIFERATIVE DISEASES

#2434
20180164318
2018-06-14

Methods for treatment of metastatic thyroid cancer using a PDGFR-α inhibitor

#2435
20180163204
2018-06-14

Micro-RNA family that modulates extracellular matrix genes and uses thereof

#2436
20180162943
2018-06-14

GM-CSF/CD40L vaccine and checkpoint inhibitor combination therapy

#2437
20180162859
2018-06-14

TETRACYCLIC AUTOTAXIN INHIBITORS

#2438
20180162811
2018-06-14

Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms

#2439
20180161429
2018-06-14

CANCER THERAPY TARGETING TETRASPANIN 33 (TSPAN33) IN MYELOID DERIVED SUPPRESSOR CELLS

#2440
20180161409
2018-06-14

Method of diagnosing preeclampsia or pregnancy-induced hypertension

#2441
20180161402
2018-06-14

Truncated von Willebrand factor polypeptides for treating hemophilia

#2442
20180161400
2018-06-14

ANTIDIABETIC ORAL INSULIN BIGUANIDE COMBINATION

#2443
20180161399
2018-06-14

TREATMENT OF CANCER WITH IMMUNE STIMULATORS

#2444
20180161387
2018-06-14

COMPOSITIONS OF HERBAL FORMULATIONS AND USES THEREOF

#2445
20180161358
2018-06-14

Compositions and methods for treating cancer

#2446
20180161354
2018-06-14

Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

#2447
20180161353
2018-06-14

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

#2448
20180161352
2018-06-14

Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

#2449
20180161351
2018-06-14

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

#2450
20180161349
2018-06-14

Arginase inhibitor combination therapies

#2451
20180161345
2018-06-14

Vaginal inserted estradiol pharmaceutical compositions and methods

#2452
20180161344
2018-06-14

Vaginal inserted estradiol pharmaceutical compositions and methods

#2453
20180161343
2018-06-14

Vaginal inserted estradiol pharmaceutical compositions and methods

#2454
20180161332
2018-06-14

Treatment of mitochondrial diseases

#2455
20180161328
2018-06-14

Treatment of cancer and benign proliferative disorders

#2456
20180161326
2018-06-14

PAC-1 combination therapy

#2457
20180161314
2018-06-14

Methods for Treating Hyperuricemia and Related Diseases

#2458
20180161311
2018-06-14

SYNTHETIC TRITERPENOIDS AND METHODS OF USE IN THE TREATMENT OF DISEASE

#2459
20180161308
2018-06-14

Self-emulsifying formulations of DIM-related indoles

#2460
20180161305
2018-06-14

Acetogenin molecules having antiplatelet and/or antithrombic activities, and methods and compositions thereof

#2461
20180161304
2018-06-14

EQUINE SUPPLEMENT

#2462
20180161303
2018-06-14

Methods and compositions for inhibition of ATR and FANCD2 activation

#2463
20180161294
2018-06-14

Broad spectrum pharmacological composition for treatmentof various infections and diseases and methodsof use

#2464
20180161285
2018-06-14

Composition and method for treating seizure disorders

#2465
20180156804
2018-06-07

Methods of developing a prognosis for pancreatic cancer and predicting responsiveness to cancer therapeutics

#2466
20180155367
2018-06-07

ETP derivatives

#2467
20180155365
2018-06-07

Tetracyclic heterocycle compounds useful as HIV integrase inhibitors

#2468
20180155189
2018-06-07

Cationic polymer coated mesoporous silica nanoparticles and uses thereof

#2469
20180154045
2018-06-07

COMPOSITIONS AND METHODS FOR URINARY BLADDER REGENERATION

#2470
20180154020
2018-06-07

Method of attacking target cells

#2471
20180154008
2018-06-07

Methods of treatment with arginine deiminase

#2472
20180154002
2018-06-07

Abuse-proof solid pharmaceutical composition

#2473
20180153996
2018-06-07

DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES

#2474
20180153969
2018-06-07

Process, tube and device for the preparation of wound healant composition

#2475
20180153936
2018-06-07

COMPOSITIONS AND METHODS OF USING LAMELLAR BODIES FOR MODIFYING LINEAR BIOLOGICAL MACROMOLECULES

#2476
20180153929
2018-06-07

Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system

#2477
20180153927
2018-06-07

Application of maltotriose-coated 4th generation poly(propyleneimine) dendrimer PPI-G4-OS-Mal-III

#2478
20180153923
2018-06-07

Synergism of GOS and polyfructose

#2479
20180153906
2018-06-07

Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids

#2480
20180153897
2018-06-07

RIBOFLAVIN FOR THE TREATMENT OF ISCHEMIC STROKE AND/OR OTHER GLUTAMATE EXCITOTOXICITY-ASSOCIATED DISEASES

#2481
20180153896
2018-06-07

Methods of treating fibrosis

#2482
20180153889
2018-06-07

MODULATION OF CELL FATES AND ACTIVITIES BY PHTHALAZINEDIONES

#2483
20180153888
2018-06-07

COMBINATION THERAPY WITH AXL INHIBITOR AND IMMUNE CHECKPOINT MODULATOR OR ONCOLYTIC VIRUS

#2484
20180153878
2018-06-07

Oral solid formulation containing irinotecan and method of preparing the same

#2485
20180153877
2018-06-07

Therapeutic targeting of myeloproliferative neoplasms by DUSP1 inhibition

#2486
20180153874
2018-06-07

PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF

#2487
20180153870
2018-06-07

BIPERIDEN FOR TREATING CANCER

#2488
20180153866
2018-06-07

Treatment of sunburn using analgesics and antihistamines

#2489
20180153864
2018-06-07

Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases

#2490
20180153863
2018-06-07

METHODS OF TREATING SOLID TUMORS USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY

#2491
20180153851
2018-06-07

Monoterpenes for treating respiratory diseases, in particular bronchopulmonary diseases

#2492
20180153849
2018-06-07

MULTI-DRUG COMBINATIONS THAT ACT AS POTENT RADIOSENSITIZERS

#2493
20180153843
2018-06-07

Anti-inflammatory omega-3 synergistic combinations

#2494
20180153840
2018-06-07

THE COMPOSITIONS OF GLYCEROL AND /OR NON-TOXIC AMINO ACIDS FOR INHIBITING AND DESTROYING BIOFILM, INCLUDING RELATED METHODS

#2495
20180153820
2018-06-07

Methods of treating pancreatic cancer

#2496
20180148688
2018-05-31

Chemical reprogramming of human glial cells into neurons with small molecule cocktail

#2497
20180147279
2018-05-31

COMBINATION THERAPY FOR NON-SMALL CELL LUNG CANCER POSITIVE FOR EGFR MUTATION

#2498
20180147264
2018-05-31

Endolysins Active Against Staphylococcus Bacteria, Pharmaceutical Compositions, and Methods Relating Thereto

#2499
20180147253
2018-05-31

Treatment of Constipation-Predominant Irritable Bowel Syndrome

#2500
20180147239
2018-05-31

Methods for culturing and/or differentiating hematopoietic stem cells into progenitors and uses thereof

#2501
20180147220
2018-05-31

Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof

#2502
20180147219
2018-05-31

Enolase inhibitors and methods of treatment therewith

#2503
20180147205
2018-05-31

Therapeutic Compositions

#2504
20180147202
2018-05-31

TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE

#2505
20180147193
2018-05-31

Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions

#2506
20180147191
2018-05-31

Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound

#2507
20180147178
2018-05-31

COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS INCLUDING SUBSTITUTED HEXITOLS SUCH AS DIANHYDROGALACTITOL AND DIACETYLDIANHYDROGALACTITOL

#2508
20180147173
2018-05-31

Compositions comprising 15-HEPE and methods of treating or preventing cancer and neurologic disease

#2509
20180147171
2018-05-31

TRANS10:CIS12 ISOMER OF CONJUGATED LINOLEIC ACID AS A THERAPEUTIC AND PREVENTATIVE AGENT FOR HYPERTENSION SPECIFIC TO PREGNANCY

#2510
20180147165
2018-05-31

METHODS FOR THE TREATMENT OF ROSACEA

#2511
20180147161
2018-05-31

MULTIDRUG BRITTLE MATRIX COMPOSITIONS

#2512
20180147159
2018-05-31

Astaxanthin anti-inflammatory synergistic combinations

#2513
20180147156
2018-05-31

Therapeutic compositions comprising monoterpenes

#2514
20180147152
2018-05-31

RAPID DISSOLVE TABLET COMPOSITIONS FOR VAGINAL ADMINISTRATION

#2515
20180146681
2018-05-31

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

#2516
20180146660
2018-05-31

Use of Recombinant Human Activated Protein C to Enhance Viability of Transplant Tissue

#2517
20180143206
2018-05-24

CXCL10 AS PREDICTIVE BIOMARKER OF RENAL TRANSPLANT ACUTE REJECTION AND DIAGNOSTIC BIOMARKER OF ANTIBODY-MEDIATED REJECTION (ABMR)

#2518
20180142008
2018-05-24

Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy

#2519
20180141990
2018-05-24

Acylated glucagon analogues

#2520
20180141938
2018-05-24

Compounds and method for treating autoimmune diseases

#2521
20180141905
2018-05-24

Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

#2522
20180140700
2018-05-24

Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibitor

#2523
20180140683
2018-05-24

Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract

#2524
20180140678
2018-05-24

Directed stem cell recruitment

#2525
20180140676
2018-05-24

Rapid-acting insulin compositions

#2526
20180140675
2018-05-24

Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders

#2527
20180140672
2018-05-24

ADMINISTRATION OF GROWTH FACTORS FOR THE TREATMENT OF CNS DISORDERS

#2528
20180140671
2018-05-24

Composition comprising connective tissue growth factor (CTGF) for cardiac tissue repair

#2529
20180140653
2018-05-24

Compositions, kits and methods for treating type II diabetes mellitus

#2530
20180140648
2018-05-24

BACTERIAL POPULATIONS FOR PROMOTING HEALTH

#2531
20180140634
2018-05-24

Enhancing the effect of car-engineered T cells by means of nucleic acid vaccination

#2532
20180140632
2018-05-24

Nutritional supplement for growth enhancement

#2533
20180140622
2018-05-24

Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

#2534
20180140612
2018-05-24

TOPICAL OPHTHALMIC FORMULATIONS FOR THE TREATMENT AND PREVENTION OF MIGRAINE HEADACHE

#2535
20180140601
2018-05-24

Bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders

#2536
20180140598
2018-05-24

TREAMENT OF T-CELL MEDIATED DISEASES

#2537
20180140594
2018-05-24

TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD

#2538
20180140592
2018-05-24

5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF

#2539
20180140584
2018-05-24

MACROPINOCYTOSIS IN CANCER

#2540
20180140579
2018-05-24

SACUBITRIL AND VALSARTAN FOR TREATING METABOLIC DISEASE

#2541
20180140573
2018-05-24

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SLEEP APNEA

#2542
20180140569
2018-05-24

Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof

#2543
20180140565
2018-05-24

Combination comprising palmitoylethanolamide (PEA) and lycopene for use in the treatment of inflammatory diseases

#2544
20180140548
2018-05-24

Two-layer separation-type eye drop containing squalane

#2545
20180135052
2018-05-17

Aptamers against glioma cells

#2546
20180134805
2018-05-17

Material and methods for treating or preventing HER-3 associated diseases

#2547
20180134737
2018-05-17

Mito-honokiol compounds and methods of synthesis and use thereof

#2548
20180134723
2018-05-17

Drug with antiviral activity (variants)

#2549
20180133369
2018-05-17

Injectable composition for in-situ repair and regeneration of an injured ligament or tendon and methods of use

#2550
20180133289
2018-05-17

C-type natriuretic peptide agent for the treatment of alopecia

#2551
20180133274
2018-05-17

Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same

#2552
20180133268
2018-05-17

COMPOSITIONS FOR A MEDICAL DEVICE COMPRISING EXOPOLYSACCHARIDE-PRODUCING BACTERIAL STRAINS IN ASSOCIATION WITH GUMS AND/OR GELATINES

#2553
20180133242
2018-05-17

COMPOSITION AND METHOD FOR PROMOTING REDUCTION OF HEAT STRESS IN ANIMALS

#2554
20180133235
2018-05-17

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

#2555
20180133234
2018-05-17

Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

#2556
20180133230
2018-05-17

Methods and compositions for treating and preventing viral infections

#2557
20180133221
2018-05-17

ADMINISTRATION OF UBIQUITIN-ACTIVATING ENZYME INHIBITOR AND CHEMOTHERAPEUTIC AGENTS

#2558
20180133219
2018-05-17

BIHETEROARYL COMPOUNDS AND USES THEREOF

#2559
20180133218
2018-05-17

FORMULATIONS, METHODS, KIT, AND DOSAGE FORMS FOR TREATING BACTERIAL INFECTION

#2560
20180133214
2018-05-17

Pharmaceutical composition for treating cancer and a method of using the same

#2561
20180133209
2018-05-17

COMBINATION OF LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE

#2562
20180133203
2018-05-17

METHODS OF TREATING LIVER DISEASE

#2563
20180133202
2018-05-17

2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders

#2564
20180133190
2018-05-17

MONOACYLGLYCEROLS AND FAT-SOLUBLE NUTRIENTS FOR USE IN THE TREATMENT OF NUTRIENT DEFICIENCY FROM MALDIGESTION

#2565
20180133157
2018-05-17

METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION

#2566
20180127719
2018-05-10

Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products

#2567
20180127717
2018-05-10

DENDRITIC CELL IMMUNOTHERAPY

#2568
20180126044
2018-05-10

Antimicrobial compositions and methods for locking catheters

#2569
20180125945
2018-05-10

STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES

#2570
20180125944
2018-05-10

STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ASPART

#2571
20180125943
2018-05-10

STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES

#2572
20180125940
2018-05-10

Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system

#2573
20180125936
2018-05-10

METHOD OF TREATING NEOPLASIAS

#2574
20180125933
2018-05-10

INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING AN OPTIMIZED HAMSTER REG3 GAMMA PEPTIDE

#2575
20180125918
2018-05-10

Formulations for the treatment and prevention of obesity

#2576
20180125908
2018-05-10

Methods of treating or preventing viral infection by using plant extracts

#2577
20180125904
2018-05-10

METHODS AND COMPOSITIONS FOR BONE AND CARTILAGE REPAIR

#2578
20180125884
2018-05-10

MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA

#2579
20180125881
2018-05-10

LINEAR POLYOL STABILIZED POLYFLUOROACRYLATE COMPOSITIONS

#2580
20180125880
2018-05-10

Composition for treating tissue lesions

#2581
20180125875
2018-05-10

Synergistic enhancement of 5-fluorouracil cytotoxicity by deoxyuridine analogs in cancer cells

#2582
20180125870
2018-05-10

Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection

#2583
20180125867
2018-05-10

COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS

#2584
20180125860
2018-05-10

Contraceptive Compositions and Methods for Improved Efficacy and Modulation of Side Effects

#2585
20180125852
2018-05-10

Compositions and methods for treatment of glioma

#2586
20180125843
2018-05-10

Method of treating metabolic disorders and depression with dopamine receptor agonists

#2587
20180125841
2018-05-10

KETOCONAZOLE ENANTIOMER IN HUMANS

#2588
20180125839
2018-05-10

Method of inhibiting mutant C-KIT

#2589
20180125837
2018-05-10

Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases

#2590
20180125831
2018-05-10

Combination therapies for treating cancer

#2591
20180125830
2018-05-10

MICROBICIDAL COMPOSITION COMPRISING AN OCTOXYNOL AND A QUINOLIZIDINE ALKALOID COMPOUND OR A SOURCE THEREOF

#2592
20180125820
2018-05-10

Sacubitril-valsartan dosage regimen for treating heart failure

#2593
20180125818
2018-05-10

Methods and compositions for treating schizophrenia

#2594
20180125817
2018-05-10

Combinations comprising a pyrrolidine-2,5-dione IDO1 inhibitor and an anti-body

#2595
20180125810
2018-05-10

Antitumoral use of cabazitaxel

#2596
20180125805
2018-05-10

PROPHYLACTIC/THERAPEUTIC AGENT FOR VIRUS INFECTIONS WHICH COMPRISES ALA COMPOUND

#2597
20180125804
2018-05-10

Synergistic famciclovir and celecoxib combination therapy for functional somatic syndromes

#2598
20180125799
2018-05-10

THERAPY FOR LEUKEMIA

#2599
20180125781
2018-05-10

MODULATION OF GEL TEMPERATURE OF POLOXAMER-CONTAINING FORMULATIONS

#2600
20180125776
2018-05-10

COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING B2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS

#2601
20180120308
2018-05-03

Matrix for receiving a tissue sample and use thereof

#2602
20180119206
2018-05-03

Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens

#2603
20180118826
2018-05-03

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease

#2604
20180118795
2018-05-03

DENDRITIC CELL INHIBITORY PROTEINS FROM TICKS

#2605
20180118766
2018-05-03

Btk inhibitors

#2606
20180118762
2018-05-03

Heteroaryls and uses thereof

#2607
20180118699
2018-05-03

SK AND IK CHANNEL AGONISTS FOR TREATMENT OF HEART FAILURE

#2608
20180118693
2018-05-03

Compounds for treatment of cancer

#2609
20180118682
2018-05-03

PHARMACEUTICAL COMPOSITION CONTAINING A TRYPTOPHAN DERIVATIVE

#2610
20180117168
2018-05-03

CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY

#2611
20180117160
2018-05-03

Method for the treatment of a solid tumour

#2612
20180117158
2018-05-03

Abuse Deterrent Pharmaceutical Composition

#2613
20180117108
2018-05-03

Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one Chamomilla plant for the treatment of cancer

#2614
20180117104
2018-05-03

Cancer therapy with a parvovirus combined with a BCL-2 inhibitor

#2615
20180117083
2018-05-03

Methods for combating bacterial infections by killing persister cells with mitomycin C and/or cisplatin

#2616
20180117081
2018-05-03

Preparations for controlled-release of hypochlorous acid

#2617
20180117078
2018-05-03

Composition and method to enhance expression of human defensin 2

#2618
20180117075
2018-05-03

Therapy for malignant disease

#2619
20180117074
2018-05-03

METHOD FOR ASSESSING AND TREATING OR PREVENTING IMPAIRED PLASMA POLAR LIPID LEVELS

#2620
20180117071
2018-05-03

Cationic polymers as co-drugs for chemotherapeutic agents

#2621
20180117068
2018-05-03

Stabilized modified release vitamin D formulation and method of administering same

#2622
20180117060
2018-05-03

COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE

#2623
20180117052
2018-05-03

COMBINATION THERAPIES FOR TREATING CANCERS

#2624
20180117044
2018-05-03

BIHETEROARYL COMPOUNDS AND USES THEREOF

#2625
20180117036
2018-05-03

ORAL PHARMACEUTICAL COMPOSITION FOR INCREASING HYPOXIA TOLERANCE

#2626
20180117034
2018-05-03

Combination therapy for cancer treatment

#2627
20180117030
2018-05-03

Bromodomain and extra-terminal protein inhibitor combination therapy

#2628
20180117029
2018-05-03

Targeting Metabolic Vulnerability in Triple-Negative Breast Cancer

#2629
20180117028
2018-05-03

Compositions and methods for treating diseases of the nail

#2630
20180117027
2018-05-03

USE OF NON-PEPTIDIC NK1 RECEPTOR ANTAGONISTS FOR THE PRODUCTION OF APOPTOSIS IN TUMOUR CELLS

#2631
20180117025
2018-05-03

Treatment method by combined use of MDM2 inhibitor and BTK inhibitor

#2632
20180117024
2018-05-03

Methods for inhibiting preterm labor and uterine contractility disorders and preventing cervical ripening

#2633
20180117015
2018-05-03

Targeting metabolic adaptive responses to chemotherapy

#2634
20180117011
2018-05-03

ENZALUTAMIDE IN COMBINATION WITH AFURESERTIB FOR THE TREATMENT OF CANCER

#2635
20180116987
2018-05-03

Treatment of pain with topical diclofenac

#2636
20180116979
2018-05-03

Memantine combinations and use

#2637
20180116977
2018-05-03

NOVEL TREATMENT OF PROSTATE CARCINOMA

#2638
20180116961
2018-05-03

Stimulant abuse-deterrent compositions

#2639
20180112282
2018-04-26

Methods for inducing cell division of postmitotic cells

#2640
20180112190
2018-04-26

Compositions and methods for viral sensitization

#2641
20180112182
2018-04-26

HIGH-THROUGHPUT IMAGE-BASED CHEMICAL SCREENING IN ZEBRAFISH BLASTOMERE CELL CULTURE

#2642
20180111999
2018-04-26

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

#2643
20180111998
2018-04-26

Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease

#2644
20180111997
2018-04-26

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease

#2645
20180111944
2018-04-26

(R)-pirlindole and its pharmaceutically acceptable salts for use in medicine

#2646
20180111907
2018-04-26

Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases

#2647
20180110888
2018-04-26

COMBINATIONS FOR THE TREATMENT OF CANCER

#2648
20180110870
2018-04-26

ExPEC glycoconjugate vaccine formulations

#2649
20180110823
2018-04-26

ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES

#2650
20180110820
2018-04-26

Compositions containing a extract incubated with a filamentous fungus of the genus

#2651
20180110809
2018-04-26

Bioassimilable protein-melanin complex, preparation and uses

#2652
20180110798
2018-04-26

Cyclodextrin for the treatment of lysosomal storage diseases

#2653
20180110793
2018-04-26

GLUTAMINE & TREHALOSE COMPOSITIONS

#2654
20180110778
2018-04-26

4,6-pyrimidinylene derivatives and uses thereof

#2655
20180110775
2018-04-26

Compositions and methods for treating mitochondrial diseases

#2656
20180110768
2018-04-26

METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS

#2657
20180110760
2018-04-26

COMPOSITIONS AND METHODS FOR THE TREATMENTOF NEURODEGENERATIVE AND OTHER DISEASES

#2658
20180110758
2018-04-26

COMPOSITIONS AND METHODS OF USING (R)-PRAMIPEXOLE

#2659
20180110756
2018-04-26

Anthracycline prodrugs and methods of making and using the same

#2660
20180110749
2018-04-26

Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer

#2661
20180110744
2018-04-26

Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit dosage forms

#2662
20180110254
2018-04-26

Gel capsule containing sterol and solubilising agent

#2663
20180105592
2018-04-19

Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease

#2664
20180105522
2018-04-19

N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use

#2665
20180105485
2018-04-19

Cyclic vinylogous amides as bromodomain inhibitors

#2666
20180104462
2018-04-19

Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device

#2667
20180104352
2018-04-19

Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof

#2668
20180104341
2018-04-19

Pharmaceutical formulations containing lipoic acid derivatives

#2669
20180104315
2018-04-19

Compositions and methods for the treatment or the prevention of infections and for the eradication or reduction of surfaces

#2670
20180104312
2018-04-19

GLUCAGON RECEPTOR AGONISTS

#2671
20180104301
2018-04-19

Formulations for the treatment of mucosal lesions

#2672
20180104299
2018-04-19

USE OF SAFFRON AND/OR SAFRANAL AND/OR CROCIN AND/OR PICROCROCIN AND/OR DERIVATIVES THEREOF AS A SATIATION AGENT FOR THE TREATMENT OF OBESITY

#2673
20180104294
2018-04-19

COMPOSITIONS AND METHODS FOR TREATING DEPRESSION

#2674
20180104275
2018-04-19

Methods and compositions for extending lifespan

#2675
20180104270
2018-04-19

COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES ASSOCIATED WITH ACTIVATED T CELLS AND/OR B CELLS

#2676
20180104268
2018-04-19

METHODS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SGLT2 INHIBITOR FOR TREATING OR IMPROVING ERECTILE DYSFUNCTION

#2677
20180104267
2018-04-19

Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

#2678
20180104259
2018-04-19

TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY

#2679
20180104258
2018-04-19

TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY

#2680
20180104257
2018-04-19

(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use

#2681
20180104256
2018-04-19

TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY

#2682
20180104249
2018-04-19

PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF

#2683
20180104241
2018-04-19

Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity

#2684
20180104239
2018-04-19

Dry powder formulation of azole derivative for inhalation

#2685
20180104236
2018-04-19

METHODS OF TREATMENT COMPRISING ADMINISTERING A HIGH DAILY DOSE OF OXYCODONE AND NALOXONE IN A 2:1 WEIGHT RATIO

#2686
20180104228
2018-04-19

Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers

#2687
20180104225
2018-04-19

Bowel cleansing composition

#2688
20180104209
2018-04-19

Prevention of psychotic disorders and/or treatment of psychotic symptoms

#2689
20180104194
2018-04-19

Antimicrobials and methods of use thereof for wound healing

#2690
20180104193
2018-04-19

Transdermal Delivery

#2691
20180104180
2018-04-19

THERMO-SENSITIVE BONE GROWTH COMPOSITIONS

#2692
20180104176
2018-04-19

Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin

#2693
20180100151
2018-04-12

Organic compositions to treat EPAS1-related diseases

#2694
20180099031
2018-04-12

DIABETES TREATMENT

#2695
20180099019
2018-04-12

Compositions and Methods for Managing Weight

#2696
20180099006
2018-04-12

USE OF ALGINATE COMPOSITIONS IN PREVENTING OR REDUCING LIVER DAMAGE CAUSED BY A HEPATOTOXIC AGENT

#2697
20180099002
2018-04-12

Tumor-selective combination therapy

#2698
20180099001
2018-04-12

DIAGNOSTICS AND METHODS FOR TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSIS AND HEPATIC STEATOHEPATITIS, AND PREVENTION OF COMPLICATIONS THEREOF

#2699
20180098999
2018-04-12

Compositions for improving cell viability and methods of use thereof

#2700
20180098995
2018-04-12

Combination Products with Tyrosine Kinase Inhibitors and their Use